Brochure: Isogen
Advanced Sterile Filling

Careful facility, equipment, and proces design underpins a secure multi-product manufacturing strategy. With the general capability to handle most classes of therapeutics including:

• Monoclonal Antibodies
• Vaccines
• Cytotoxic and Cytostatics
• BSL 2, Live Virus Products, etc

Isogen executes a case specific risk assessment program aimed at demonstrating complete clearance of each product hence eliminating product cross contamination prior to bringing individual agents into the facility.